umu.sePublikationer
Ändra sökning
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Obstetrik och gynekologi.
Umeå universitet, Medicinska fakulteten, Institutionen för farmakologi och klinisk neurovetenskap, Farmakologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Obstetrik och gynekologi.
Umeå universitet, Medicinska fakulteten, Institutionen för klinisk vetenskap, Obstetrik och gynekologi.
2004 (Engelska)Ingår i: Psychoneuroendocrinology, ISSN 0306-4530, E-ISSN 1873-3360, Vol. 29, nr 6, s. 767-777Artikel i tidskrift (Refereegranskat) Published
Ort, förlag, år, upplaga, sidor
2004. Vol. 29, nr 6, s. 767-777
Nyckelord [en]
Adult, Alcoholic Intoxication/physiopathology, Analysis of Variance, Central Nervous System Depressants/administration & dosage, Double-Blind Method, Estradiol/blood, Ethanol/*administration & dosage, Female, Follicular Phase/blood/*drug effects, Humans, Infusions; Intravenous, Luteal Phase/blood/*drug effects, Middle Aged, Premenstrual Syndrome/blood/*physiopathology, Progesterone/blood, Reference Values, Saccades/*drug effects/physiology
Identifikatorer
URN: urn:nbn:se:umu:diva-16946DOI: 10.1016/S0306-4530(03)00121-5PubMedID: 15110926OAI: oai:DiVA.org:umu-16946DiVA, id: diva2:156619
Tillgänglig från: 2007-10-22 Skapad: 2007-10-22 Senast uppdaterad: 2018-06-09Bibliografiskt granskad
Ingår i avhandling
1. Premenstrual dysphoric disorder in relation to neuroactive steroids and alcohol
Öppna denna publikation i ny flik eller fönster >>Premenstrual dysphoric disorder in relation to neuroactive steroids and alcohol
2006 (Engelska)Doktorsavhandling, sammanläggning (Övrigt vetenskapligt)
Abstract [en]

Introduction: Premenstrual Dysphoric Disorder (PMDD) is a condition that affects about 2-6% of women of reproductive age. The relation to ovarian steroids is apparent as symptoms are absent during anovulatory cycles. Neuroactive steroids like allopregnanolone have effect in the brain and on brain function and have been proposed to play an important role for the symptomatology of premenstrual symptoms and in the interaction between the GABAA receptor and alcohol. High doses of alcohol elevate allopregnanolone levels both in rats and humans. Allopregnanolone is a positive modulator of the GABAA receptor with sedative, anxiolytic and anticonvulsant effect in both human and animals.

Aims: The aim was to investigate if a low dose (100μg) of GnRH agonist (buserelin) is effective for the treatment of PMDD and if allopregnanolone serum levels during treatment are associated to symptom severity. Furthermore, the studies aimed at investigating the effect of a low dose of alcohol upon saccadic eye movements in women with PMDD, and control subjects in different phases of the menstrual cycle, and to evaluate if there was a difference in response to alcohol between men and healthy women. We also wanted to see if this low dose of alcohol could have an effect on serum allopregnanolone levels in women with PMDD and control subjects in the follicular and luteal phases of the menstrual cycle.

Methods: The effect of low dose (100μg) of GnRH agonist (buserelin) on premenstrual symptoms was evaluated in a randomized, placebo controlled, double-blinded cross-over trial. 27 PMDD patients were randomized to either GnRH agonist intranasally once a day or placebo for two months before the crossover. The main outcome measure was the daily symptom ratings for mood and physical symptoms made by the patients. In a subgroup of 12 women, grouped as buserelin responders and placebo responders, luteal phase serum progesterone, allopregnanolone, and pregnanolone was measured together with daily ratings for mood and physical symptoms. Alcohol responsiveness was measured in PMDD patients, female control subjects and men by comparing the effect of a low dose (0.2g/kg) of intravenous alcohol or placebo infusion upon saccadic eye movements. Blood samples for measurement of allopregnanolone and cortisol were taken throughout the alcohol/placebo challenges.

Results: Low dose GnRH agonist was effective as treatment of premenstrual irritability and depression. Anovulatory cycles were confirmed in 56% of the subjects, particularly in older women. Buserelin as well as placebo responders displayed decreased allopregnanolone and progesterone levels in parallel with symptom improvement. PMDD patients displayed blunted saccadic eye movement response to alcohol infusion, especially in the luteal phase. Control subjects did not change their response to alcohol between cycle phases. We found no difference in saccadic eye movement sensitivity to alcohol between males and females. Allopregnanolone levels significantly decreased in the luteal phase following the alcohol infusion.

Conclusions: Low dose GnRH agonist is effective in treatment of premenstrual depression and irritability but is likely to induce anovulation with increasing age. Independent of whether buserelin or placebo treatment was given decreased levels of allopregnanolone appear to be related to symptom improvement. Women with PMDD have altered saccadic eye movement sensitivity in response to alcohol, particularly in the luteal phase. The low dose of alcohol did not induce any difference in saccade measurements between males and females. Low dose of alcohol does not result in increased peripheral levels of allopregnanolone.

Ort, förlag, år, upplaga, sidor
Umeå: Umeå university, 2006. s. 88
Serie
Umeå University medical dissertations, ISSN 0346-6612 ; 1057
Nyckelord
premenstrual dysphoric disorder, GnRH-agonist, progesterone, allopregnanolone, alcohol, saccadic eye velocity
Forskningsämne
obstetrik och gynekologi
Identifikatorer
urn:nbn:se:umu:diva-937 (URN)91-7264-175-4 (ISBN)
Disputation
2006-12-15, Hörsal Betula, 6M, NUS, Umeå, 09:00 (Engelska)
Opponent
Tillgänglig från: 2006-11-21 Skapad: 2006-11-21 Senast uppdaterad: 2011-04-07Bibliografiskt granskad

Open Access i DiVA

Fulltext saknas i DiVA

Övriga länkar

Förlagets fulltextPubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=15110926&dopt=Citation

Personposter BETA

Nyberg, SigridBäckström, Torbjörn

Sök vidare i DiVA

Av författaren/redaktören
Nyberg, SigridBäckström, Torbjörn
Av organisationen
Obstetrik och gynekologiFarmakologi
I samma tidskrift
Psychoneuroendocrinology

Sök vidare utanför DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetricpoäng

doi
pubmed
urn-nbn
Totalt: 181 träffar
RefereraExporteraLänk till posten
Permanent länk

Direktlänk
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annat format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annat språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf